IBDEI107 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16141,1,3,0)
 ;;=3^Primary Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,16141,1,4,0)
 ;;=4^E27.1
 ;;^UTILITY(U,$J,358.3,16141,2)
 ;;=^5002740
 ;;^UTILITY(U,$J,358.3,16142,0)
 ;;=E27.2^^88^872^1
 ;;^UTILITY(U,$J,358.3,16142,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16142,1,3,0)
 ;;=3^Addisonian Crisis
 ;;^UTILITY(U,$J,358.3,16142,1,4,0)
 ;;=4^E27.2
 ;;^UTILITY(U,$J,358.3,16142,2)
 ;;=^263725
 ;;^UTILITY(U,$J,358.3,16143,0)
 ;;=E27.3^^88^872^4
 ;;^UTILITY(U,$J,358.3,16143,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16143,1,3,0)
 ;;=3^Drug-induced Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,16143,1,4,0)
 ;;=4^E27.3
 ;;^UTILITY(U,$J,358.3,16143,2)
 ;;=^5002741
 ;;^UTILITY(U,$J,358.3,16144,0)
 ;;=E29.1^^88^872^35
 ;;^UTILITY(U,$J,358.3,16144,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16144,1,3,0)
 ;;=3^Testicular Hypofunction
 ;;^UTILITY(U,$J,358.3,16144,1,4,0)
 ;;=4^E29.1
 ;;^UTILITY(U,$J,358.3,16144,2)
 ;;=^5002754
 ;;^UTILITY(U,$J,358.3,16145,0)
 ;;=E55.9^^88^872^42
 ;;^UTILITY(U,$J,358.3,16145,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16145,1,3,0)
 ;;=3^Vitamin D Deficiency,Unspec
 ;;^UTILITY(U,$J,358.3,16145,1,4,0)
 ;;=4^E55.9
 ;;^UTILITY(U,$J,358.3,16145,2)
 ;;=^5002799
 ;;^UTILITY(U,$J,358.3,16146,0)
 ;;=E66.01^^88^872^20
 ;;^UTILITY(U,$J,358.3,16146,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16146,1,3,0)
 ;;=3^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,16146,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,16146,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,16147,0)
 ;;=E66.8^^88^872^24
 ;;^UTILITY(U,$J,358.3,16147,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16147,1,3,0)
 ;;=3^Obesity NEC
 ;;^UTILITY(U,$J,358.3,16147,1,4,0)
 ;;=4^E66.8
 ;;^UTILITY(U,$J,358.3,16147,2)
 ;;=^5002831
 ;;^UTILITY(U,$J,358.3,16148,0)
 ;;=E66.9^^88^872^25
 ;;^UTILITY(U,$J,358.3,16148,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16148,1,3,0)
 ;;=3^Obesity,Unspec
 ;;^UTILITY(U,$J,358.3,16148,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,16148,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,16149,0)
 ;;=E74.39^^88^872^16
 ;;^UTILITY(U,$J,358.3,16149,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16149,1,3,0)
 ;;=3^Intestinal Carbohydrate Absorption Disorder NEC
 ;;^UTILITY(U,$J,358.3,16149,1,4,0)
 ;;=4^E74.39
 ;;^UTILITY(U,$J,358.3,16149,2)
 ;;=^5002928
 ;;^UTILITY(U,$J,358.3,16150,0)
 ;;=E83.30^^88^872^28
 ;;^UTILITY(U,$J,358.3,16150,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16150,1,3,0)
 ;;=3^Phosphorus Metabolism Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,16150,1,4,0)
 ;;=4^E83.30
 ;;^UTILITY(U,$J,358.3,16150,2)
 ;;=^5002997
 ;;^UTILITY(U,$J,358.3,16151,0)
 ;;=E83.51^^88^872^9
 ;;^UTILITY(U,$J,358.3,16151,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16151,1,3,0)
 ;;=3^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,16151,1,4,0)
 ;;=4^E83.51
 ;;^UTILITY(U,$J,358.3,16151,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,16152,0)
 ;;=E83.52^^88^872^7
 ;;^UTILITY(U,$J,358.3,16152,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16152,1,3,0)
 ;;=3^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,16152,1,4,0)
 ;;=4^E83.52
 ;;^UTILITY(U,$J,358.3,16152,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,16153,0)
 ;;=E87.5^^88^872^8
 ;;^UTILITY(U,$J,358.3,16153,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16153,1,3,0)
 ;;=3^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,16153,1,4,0)
 ;;=4^E87.5
 ;;^UTILITY(U,$J,358.3,16153,2)
 ;;=^60041
 ;;^UTILITY(U,$J,358.3,16154,0)
 ;;=E89.2^^88^872^30
